Evidence-based medication selection for Type 1 and Type 2 Diabetes
Goal: <70 mg/dL
The standard goal for most non-pregnant adults is <7.0%. However, goals should be individualized: <6.5% for younger/healthier patients, and <8.0% for older patients or those with significant comorbidities.
Type 1 is an autoimmune condition where the body stops producing insulin. Type 2 is characterized by insulin resistance and relative insulin deficiency. Treatment approaches differ significantly.
Beyond lowering blood sugar, these newer medication classes have been proven to protect the heart and kidneys (cardiorenal protection) and often promote weight loss.